Introduction
Calcineurin inhibitors (CNIs) such as cyclosporine A (CsA) and tacrolimus are widely used immunosuppressants in solid organ transplantation. CNIs efficiently inhibit interleukin (IL)-2 transcription and therefore ultimately prevent T cell activation [1, 2] . In addition, CNIs reduce the frequency and function of CD4þ regulatory T cells (Tregs) and upregulates T helper type 17 (Th17) cellassociated pathways [3e6] . It is well known that Th17 secretes proinflammatory cytokine IL-17 [7, 8] and is regulated by signal transducer and activator of transcription (STAT) 3. By contrast, the Treg population is associated with immune tolerance and is regulated by STAT5, which binds to the forkhead box P3 (Foxp3) promoter [9e11] . A recent paper suggested a competition model in which relative activation of STAT3 and STAT5 directly dictates the outcome of IL-17 production in CD4þ T cells [12] .
Recently, ginseng has received attention as a potential therapy for preventing autoimmune and allogeneic immune disorders [13e 15]. Interestingly, Jhun et al. [16] suggested that Korean Red Ginseng (KRG) could ameliorate arthritis in mice with collageninduced arthritis, through suppression of Th17 differentiation by inhibiting phosphorylation of STAT3 and reciprocally increasing Treg population. Based on these observations of STAT3 inhibition by ginseng, it is expected that combined treatment of KRG would suppress the differentiation of pathogenic Th17 cells through the inhibition of STAT3 during CsA treatment.
Therefore, we designed this study to evaluate the influence of KRG on CsA-induced immunosuppression using isolated CD4þ splenocytes. First, we verified the frequency and expression of the Th17 and Treg cells as well as Th1 and Th2 during stimulation with the T cell receptor (TCR). Second, we further examined those affected by stimulation of alloantigen, which is mimicking rejection conditions. We also tested the expression of phosphorylation of STAT3 and STAT5 as the regulation mechanism of Th17 and Treg.
Materials and methods

Mice and drugs
C57BL/6 (H-2Kb) and BALB/c (H-2Kd) mice, 8e10-wk-old, were purchased from OrientBio (Sungnam, Korea). The mice were maintained under specific pathogen-free conditions in an animal facility with controlled humidity (55 AE 5%), light (12 h/12 h light/ dark), and temperature (22 AE 1 C). The air in the clean bench was passed through a high efficiency particulate air filter system designed to eliminate bacteria and viruses. Mice were fed animal chow and tap water ad libitum. The animal protocol was approved by the Animal Care and Use Committee of the Catholic University of Korea. CsA (Sigma-Aldrich, St. Louis, MO, USA) was diluted in sterile phosphate-buffered saline. KRG extract (KRGE) was obtained from Korea Ginseng Corporation (Seoul, Korea) and was diluted in sterile phosphate-buffered saline. According to the manufacturer's data, the main components of the KRGE were Rg1 (2.01%), Rb1 (8.27%), Rg3 (1.04%), Re (2.58%), Rc (3.90%), Rb2 (3.22%), Rd (1.09%), Rf (1.61%), Rh1 (0.95%), and Rg2 (s) (1.35%).
Cytotoxicity assay
Cell viability was assessed using propidium iodide (PI) staining solution (BD Biosciences, San Jose, CA, USA). Isolated CD4þ T cells were cultured with various concentrations of CsA (3 ng/mL, 10 ng/ mL, 30 ng/mL, 60 ng/mL) or KRGE (3 mg/mL, 10 mg/mL, 30 mg/mL) for 72 h. Viable and dead cells were distinguished using flow cytometric analysis on a fluorescence-activated cell sorting LSRII Fortessa (BD Biosciences).
CD4þ T cell isolation and differentiation
Spleens were removed from C57BL/6 mice and minced. Splenic red blood cells were removed with ammonium-chloride-potassium lysis buffer (0.15M NH 4 Cl, 1mM KHCO 3 , 0.1mM Na 2 EDTA, pH 7.2w7.4). The cells were resuspended in complete media containing RPMI 1640 supplemented with 5% fetal bovine serum and 1% antibiotics (all from Gibco, Grand Island, NY, USA). CD4þ T cells were isolated using a CD4þ T cell isolation kit (Miltenyi Biotec, San Diego, CA, USA), according to the manufacturer's protocol. The purity of isolated CD4þ T cells was assessed as > 95%. Negatively selected non-CD4þ cells were regarded as antigen-presenting cells (APCs) and irradiated at 3,000 rad before coculture. Isolated CD4þ T cells were stimulated with plate-bound anti-CD3 (0.5 mg/mL) and soluble anti-CD28 (1 mg/mL) (both from BD Biosciences) in the presence or absence of CsA (30 ng/mL) and KRGE (3 mg/mL or 10 mg/ mL) for 72 h. For Th17 cell-polarizing condition, isolated CD4þ T cells were stimulated with plate-bound anti-CD3 mAb (0.5 mg/mL), soluble anti-CD28 mAb (1 mg/mL), anti-interferon (IFN) g (2 mg/ mL), anti-IL-4 (2 mg/mL), anti-IL-2 (2 mg/mL), IL-6 (20 ng/mL) (all from R&D Systems, Minneapolis, MN, USA), and transforming growth factor-beta (2 ng/mL, PeproTech, London, UK) for 72 h [16, 17] .
Flow cytometry
Expression of cytokines and transcription factors was assessed by intracellular staining. The following antibodies were used for intracellular staining of mouse cells: anti-CD4-peridinin chlorophyll or -fluorescein isothiocyanate, anti-CD25-eFluor 450, anti-IL-17-phycoerythrin (PE), anti-Foxp3-allophycocyanin (APC), antiIFNg-peridinin chlorophyll-cyanine 5.5, and anti-IL-4-PE-cyanine 7 (all from eBioscience, San Diego, CA, USA). Cells were stimulated for 4 h with phorbol 12-myristate 13-acetate (Sigma) and ionomycin (Sigma) with the addition of GolgiStop (BD Bioscience). Intracellular staining was performed using an intracellular staining kit (eBioscience) according to the manufacturer's protocol. To examine the expression of phosphorylated STAT (p-STAT)3 and p-STAT5, cultured cells were stimulated with IL-6 for 30 min before harvesting and were stained with anti-p-STAT3-PE and anti-p-STAT5-Alexa Fluor 488 (both from BD Bioscience). Appropriate isotype controls were used for gate setting. Cells were analyzed on fluorescence-activated cell sorting LSRII Fortessa, and the data were analyzed with FlowJo software version 7.6 (Tree star, Ashland, OR, USA). The experiments were conducted at least three times. The experiments were performed with individual samples from separate experiments and not using different wells from the same culture plate.
Quantitation of subset of CD4þT cell by flow cytometry
In the analysis of the subsets of CD4þ T cells, the lymphocyte population was divided by the forward-scattered light/side-scattered light. From this primary gate, CD4þ T cells are identified by their expression of CD4 and their characteristic light scatter properties. From this CD4þ T cell gating, relative percentages of interested cell populations (e.g., IFNgþ, IL-4þ, IL-17þ, CD25þFoxp3þ, p-STAT3þ, p-STAT5þ) were identified by drawing around the enlarged cluster and by subtracting isotype control versus side scatter analysis. The results are expressed as the mean of triplicate samples AE the standard deviation (SD).
Enzyme-linked immunosorbent assay
Antibodies to IFNg, IL-4, and IL-17 were obtained from R&D Systems. The concentrations of IFNg, IL-4, and IL-17 in the culture supernatants were measured by sandwich enzyme-linked immunosorbent assay (ELISA), according to the manufacturer's instruction. A standard curve was drawn by plotting the optical density versus the log of the concentration of IFNg, IL-4, or IL-17.
Mixed lymphocyte reactions culture in vitro
CD4þ T cells derived from C57BL/6 mice were used as the responder cells and irradiated non-CD4þ cells derived from BALB/c or C57BL/6 mice were used as APC for allogeneic or syngeneic stimulator cells, respectively. The cells were resuspended in complete media containing RPMI 1640 supplemented with 5% fetal bovine serum and 1% antibiotics. Aliquots of 2 Â 10 5 CD4þ T cells were cultured with 2 Â 10 5 irradiated (3,000 cGy) APCs in 96-well plates containing 200 mL of complete medium and were incubated for 72 h. Cocultured cells were pulsed with 1 mCi of ( 3 H)-TdR (thymidine) (NEN Life Science, Boston, MA, USA) for 18 h before harvesting and were counted using an automated harvester (PHD Cell Harvester, Cambridge Technology, Cambridge, MA, USA). The results are expressed as the mean count/min of triplicate samples AE the SD.
Statistical analysis
One-way analysis of variance and the paired-samples t test were applied using SPSS software (version 19.0; IBM, Armonk, NY, USA). Data are shown as mean AE SD. A p value < 0.05 was taken to be significant.
Results
Determination of the doses of KRGE and CsA
First, we used PI staining to determinate the noncytotoxic concentrations of KRGE and CsA. CD4þ T cells isolated from splenocytes were exposed to various concentrations of CsA (3 ng/mL, 10 ng/mL, 30 ng/mL, and 60 ng/mL) and KRGE (3 mg/mL, 10 mg/mL, and 30 mg/mL) when stimulated with anti-CD3 and anti-CD28 antibodies. In this assay, the viable cells are negative for PI uptake and dead cells are positive for PI uptake (PIþ), as shown in Fig. 1A . The percentages of dead cells did not differ between control and KRGEtreated cells at 3e30 ng/mL of CsA (Figs. 1BeD) . However, the percentage of dead cells was significantly higher at 60 ng/mL of CsA compared with the control condition (p < 0.05). Based on these results, we used the concentrations of 3 mg/mL and 10 mg/mL for KRGE and 30 mg/mL for CsA for further studies.
Influence of KRGE treatment on differentiation of Th1 and Th2 cells during CsA treatment
To determine the impact of CsA and KRGE on the differentiation of Th1 cells from naïve CD4þ T cells under distinct stimulating conditions, CD4þ T cells were treated with or without CsA and KRGE under stimulation with anti-CD3 and anti-CD28 antibodies to activate naïve CD4þ T cells. Th1 cells were identified as the IFNgþ population of CD4þ cells (CD4þIFNgþ) by flow cytometry (Fig. 2) , and the IFNg concentration in the CD4þ T cell cultured supernatant was measured by ELISA. The resulting fluorescence profiles showed that CsA reduced the differentiation of Th1 cells (p < 0.05), but that KRGE did not affect the differentiation of Th1 cells (Fig. 3A, B) . The IFNg concentration in the culture supernatant was also reduced by CsA (p < 0.001), but not by KRGE (Fig. 3C) . We assessed the influence of KRGE on the differentiation of Th2 cells in the CsA-treated condition. Differentiated Th2 cells were identified as IL-4þ cells in the CD4þ T cell population (CD4þIL-4þ) using flow cytometry (Figs. 3D, E), and IL-4 concentration was measured by ELISA in the CD4þ T cell cultured supernatant (Fig. 3F) . The resulting fluorescence profile showed that neither CsA nor KRGE affected the differentiation of Th2 cells or the production of IL-4. 
Influence of KRGE on the alloreactive T cell response under CsA treatment
To assess the effects of KRGE on the proliferative capacity of donor CD4þ T cells in response to alloantigens following transplantation, the alloreactivity of T cells was measured by ( 3 H)-thymidine incorporation to assess T cell proliferation in the mixed lymphocyte reaction (MLR). A proliferative response to BALB/c cells (allogeneic stimulator) was observed in C57BL/6 CD4þ T cells (responder cells). KRGE had no significant effect on this alloreactive T cell response, whereas CsA inhibited the alloreactivity-induced proliferation of T cells by inhibiting T cell activation (p < 0.001). The alloreactivity-induced proliferation of T cells was inhibited further by KRGE compared with CsA-only treatment (p < 0.05; Fig. 6A ). Cytokine concentrations were measured in the supernatant from the coculture of allogeneic stimulator and responder cells. Both IL-17 production by Th17 cells and IFNg production by Th1 cells were significantly reduced by KRGE in cells cotreated with RGE and CsA compared with CsA-only treatment (p < 0.05). By contrast, IL-4 production by Th2 cells was not influenced by KRGE and CsA (Fig. 6B) .To investigate the effects of KRGE on immune tolerance during the allogeneic T cell response, we assessed the differentiation of Tregs in response to alloantigens following transplantation. The resulting fluorescence profile showed that the increase in the number of Foxp3þCD25þ Tregs in the allogeneic CD4þ T cell population was reduced by CsA treatment (p < 0.05). By contrast, KRGE recovered the differentiation of Tregs under stimulation with CsA (p < 0.05; Fig. 6C ).
Discussion
The present study was undertaken to investigate the effect of ginseng on the subpopulation of CD4þ T cells and the ability of these cells to produce cytokines during CsA treatment after stimulation with the TCR or alloantigen. We found that the combined treatment with KRGE and CsA did not affect the differentiation of naïve T cells into Th1 or Th2 cells or their ability to produce their related cytokines. Interestingly, the Th17 cell population and its transcription factor STAT3 were suppressed significantly by KRGE, and the CsA-induced suppression of Treg differentiation was markedly recovered by KRGE treatment. Overall, our results provide evidence that supplementation with ginseng has beneficial effects against CsA-based immunosuppression.
First, we investigated the effect of KRGE on the differentiation of Th1/Th2 cells under CsA treatment, because published data have indicated that CD4þ Th1 cells are involved in allograft rejection [18] . Our results showed that CsA inhibited the differentiation of CD4þIFNgþ and production of IFNg but did not alter CD4þIL-4þ cells and production of IL-4. CsA is known to downregulate IL-2 synthesis, thereby inhibiting Th1, CD8, and natural killer cells functions and IFNg synthesis. In a study of clinical transplantation, CD4þ T cell clones isolated from human kidney allografts during acute rejection produced a high concentration of IFNg, but not of IL-4 or IL-5, after stimulation with phytohemagglutinin, indicating that alloreactive Th1 cells, but not Th2 cells, are involved in the acute allograft rejection [19] . Similarly, it is known that ginseng extract or its components (e.g., Re or Rg1) suppress IFNg secretion in response to immune activation, which increases cell viability [20, 21] . In this study, when used together in the nontoxic dose range, KRGE did not add to the CsA-induced suppression of CD4þIFNgþ cells or to the reduced IFNg concentration in the cell medium. KRGE treatment had no effect on the differentiation of CD4þIL-4þ Th2 cells or the secretion of the cytokine IL-4. These findings suggest that KRGE treatment does not influence CsA-based suppression of Th1 cells. Next, we investigated the influence of KRGE on the differentiation of Th17 cells during CsA treatment based on accumulating evidence that Th17 cells are implicated in allograft rejection. The Th17 cell is a third subset of effector T cells and is characterized by the secretion of the proinflammatory cytokine IL-17 [7, 8] . Th17 cells act through the secretion of IL-17, which recruits monocytes and neutrophils, and acts in synergy with other local inflammatory cytokines [22] . In this study, we found that CsA treatment significantly inhibited the population of CD4þIL-17þ cells and the IL-17 concentration in the supernatant and that cotreatment with KRGE further reduced both parameters. Interestingly, p-STAT3, a main transcription factor in Th17 cells [23, 24] , was suppressed significantly by KRGE treatment. This finding confirms that KRGE can inhibit the differentiation of Th17 cells by inhibiting the transcription of Th17.
There is emerging evidence that allograft function correlates with the number of Tregs [25] . However, CsA inhibits the generation of Tregs by inhibiting IL-2 transcription in the thymus and periphery, and inhibition of calcineurin by CsA restricts the access of the nuclear factor for Foxp3 [26] . In this study, we tested whether KRGE treatment would be effective in inducing Tregs, whose induction is inhibited by CsA-based immunosuppression. We found that CsA inhibition of the CD4þCD25þFoxp3þ Treg population was recovered by KRGE treatment. p-STAT5, a transcription factor in Tregs, was also consistently increased by KRGE treatment. This finding confirms the effect of ginseng on the generation of Tregs in immune disorders such as autoimmune encephalomyelitis and atopic dermatitis [13, 27] .
Reciprocal regulation of Th17 cells and Tregs has been proposed recently in a competition model, in which the relative activation of STAT3 and STAT5 directly dictates the outcome of IL-17 production in CD4þ T cells [12] . It was demonstrated that STAT3 and STAT5 bind to multiple common sites across the locus encoding IL-17 and that the induction of STAT5 binding by IL-2 is associated with less binding of STAT3 at these sites. Therefore, therapeutic agents that inhibit STAT3 may simultaneously upregulate STAT5. Consistent with these findings, our results showed that KRGE upregulated Foxp3 expression in CD4þ T cells even in conditions fostering Th17 cell differentiation. In addition, KRGE increased the number of Tregs that expressed Foxp3 or STAT5, both of which are critical transcription factors in Treg cells (Figs. 5 and 6 ). These findings suggest that ginseng treatment is beneficial by reciprocally regulating Th17 and Treg cells during CsA treatment.
B C
In this study to extend our previous findings, we confirmed the in vitro alloreactive CD4þ T cell response to KRGE when administered with CsA in an MLR. Wang et al. reported that the ginsenoside Rd by itself has immunosuppressive effects on skin allograft rejection in rats [28] , but they did not compare this effect when combined with CsA. In our study, the combined treatment of KRGE and CsA suppressed alloreactive T cell proliferation (Fig. 6 ). This result suggests that KRGE treatment may play an important role in regulating transplant rejection, although this requires confirmation by in vivo studies.
Our study has some limitations. First, we determined the noncytotoxic concentration of CsA and KRGE for lymphocytes in an in vitro study, as shown in Fig. 1 CsA and KRGE in vivo. Second, in this study, we selected two doses of KRGE (3 mg/mL and 10 mg/mL) based on the results of cellular toxicity ( Fig. 1) and a preliminary test of subset of CD4þT cells. Much lower or high doses of KRGE did not influence CsA effects.
We expected dose-dependent effects between 3 mg/mL and 10 mg/ mL of KRGE but could not get statistical significance, although there was tendency to dose-dependency. Third, we applied commercial KRGE rather than specific ginsenoside compounds. It would be valuable to study the functions of specific constituents of ginseng, because ginseng extracts contain multiple functional constituents. In this study, combined treatment of KRGE minimally changed the population of Th17 cells or Treg cells against CsA-based immunosuppression. Therefore, we suggest several possibilities. First, because CsA itself is too strong an immunosuppressant, changes of subset of CD4þT cells are not easy to detect, unlike immune activation-related diseases (e.g., autoimmune arthritis, autoimmune encephalomyelitis, and atopic dermatitis). Otherwise, indeed, the immune-modulatory effect of KRGE may be too weak to recover during CsA treatment. However, cotreatment with KRGE did not show side effects on CsA-induced immune suppression at least. Therefore, we suggest that supplements of KRGE should be taken as subside materials in transplant patients receiving CsA.
In conclusion, combined treatment with ginseng showed immunologic safety in CsA-based immunosuppression. It also acts as an immune regulator through the reciprocal regulation of Th17 and Treg cells. These findings provide a rationale for the use of ginseng in transplant and immune-disorder patients receiving with CsA. 
